Ariel Investments LLC Reduces Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Ariel Investments LLC reduced its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 0.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,762,023 shares of the company's stock after selling 20,817 shares during the period. Prestige Consumer Healthcare makes up approximately 2.3% of Ariel Investments LLC's holdings, making the stock its 13th largest holding. Ariel Investments LLC owned approximately 5.59% of Prestige Consumer Healthcare worth $215,686,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Kayne Anderson Rudnick Investment Management LLC acquired a new stake in shares of Prestige Consumer Healthcare in the fourth quarter valued at approximately $84,932,000. Raymond James Financial Inc. acquired a new stake in Prestige Consumer Healthcare in the fourth quarter worth $42,593,000. Norges Bank bought a new stake in Prestige Consumer Healthcare in the 4th quarter valued at about $40,009,000. Bessemer Group Inc. lifted its holdings in shares of Prestige Consumer Healthcare by 10,053.1% in the 4th quarter. Bessemer Group Inc. now owns 295,050 shares of the company's stock worth $23,041,000 after purchasing an additional 292,144 shares in the last quarter. Finally, Boston Trust Walden Corp grew its holdings in shares of Prestige Consumer Healthcare by 43.5% during the fourth quarter. Boston Trust Walden Corp now owns 831,627 shares of the company's stock valued at $64,942,000 after buying an additional 252,089 shares during the last quarter. 99.95% of the stock is owned by institutional investors.

Analysts Set New Price Targets

PBH has been the topic of a number of research reports. StockNews.com raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Tuesday, April 29th. Canaccord Genuity Group upped their target price on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. Royal Bank of Canada boosted their price objective on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the stock a "sector perform" rating in a report on Friday, March 21st. Oppenheimer boosted their price objective on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an "outperform" rating in a research report on Thursday, February 13th. Finally, DA Davidson upped their price target on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, Prestige Consumer Healthcare has a consensus rating of "Moderate Buy" and a consensus price target of $93.33.

Insider Buying and Selling

In other news, SVP Mary Beth Fritz sold 1,678 shares of the business's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $90.00, for a total transaction of $151,020.00. Following the transaction, the senior vice president now owns 17,157 shares of the company's stock, valued at approximately $1,544,130. The trade was a 8.91 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.60% of the stock is currently owned by corporate insiders.

Prestige Consumer Healthcare Trading Down 2.4 %

NYSE:PBH traded down $1.99 during mid-day trading on Tuesday, hitting $80.99. 412,461 shares of the stock traded hands, compared to its average volume of 291,972. Prestige Consumer Healthcare Inc. has a 52 week low of $62.35 and a 52 week high of $90.04. The stock has a market capitalization of $4.01 billion, a price-to-earnings ratio of 18.97, a PEG ratio of 2.69 and a beta of 0.47. The firm's 50 day moving average is $83.21 and its two-hundred day moving average is $81.11. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. On average, equities research analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.